← Back

Utah Medical Products Inc

Utah Medical Products, Inc. provides medical devices to the healthcare industry in the United States, Europe, and internationally. Its products include fetal monitoring accessories, vacuum-assisted delivery systems, infant respiratory hoods, blood pressure monitoring systems, and a range of neonatal and women's health devices such as catheters, feeding devices, and electrosurgical tools. The company serves neonatal intensive care units, labor and delivery departments, women's health centers, outpatient clinics, and physician's offices. Incorporated in 1978, it is headquartered in Midvale, Utah.

Country
Price · split & dividend adjusted
News & notes moving UTMD
UTMD▲

Femcare acquires Orion Medical for £3.6M

Utah Medical Products announced that its Femcare unit has acquired all ordinary shares of U.K.-based Orion Medical Supplies for £3.6 million in cash. The deal is expected to add approximately $6 million to annual sales, with potential for further geographic expansion. The acquisition is expected to benefit margins by leveraging Femcare's existing infrastructure, and the company plans to integrate Orion's operations into Femcare's existing Romsey facilities. Shares rose 1.35% following the announcement.
UTMD ▲
Seeking Alpha·18dRead more →
UTMD▲

Utah Medical Products declares $0.31 quarterly dividend

Utah Medical Products declared a quarterly dividend of $0.31 per share, matching the previous payout. The dividend is payable on October 5 to shareholders of record as of September 17, with the ex-dividend date also set for September 17.
UTMD ▲
Seeking Alpha·45dRead more →
UTMD▼

Utah Medical Products Reports 14% Revenue Drop in Second Quarter 2026

Utah Medical Products reported a 14.3% decline in second-quarter 2026 revenues to $8,529 thousand, driven by the loss of sales to its two previously largest customers. The combined sales to those two entities, which were zero in the second quarter of 2026, had been $1,066 thousand in the same period of 2025, accounting for 75% of the quarterly decline. Net income fell 11.9% to $2,686 thousand, or $0.844 per diluted share, as higher litigation expenses and lower gross profit offset a lower tax rate. For the first half of 2026, revenues decreased 12.3% to $17,252 thousand, and management now projects a full-year sales decline of 10% to 13% compared to 2025, citing slower-than-expected new product sales. The company maintained a strong balance sheet with no debt, ending the quarter with $87.5 million in cash and investments.
UTMD ▼
ACCESS Newswire·57dRead more →
© 2026 MarketDXAsset